ELCC 2022 | Impact of COVID-19 on academic research

Matthijs Oudkerk, MD, PhD, University of Groningen, Groningen, Netherlands, provides an overview of the impact of the COVID-19 pandemic on lung cancer screening programmes, touching on consequences in the academic research setting and clinical trial develoment. This interview took place during the virtual European Lung Cancer Congress 2022.